Found: 47
Select item for more details and to access through your institution.
Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad335
- By:
- Publication type:
- Article
In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 7, p. N.PAG, doi. 10.1093/ofid/ofy158
- By:
- Publication type:
- Article
Pediatric and Adult Recommendations Vary for Sibling Testing in Cystic Fibrosis.
- Published in:
- Journal of Genetic Counseling, 2018, v. 27, n. 5, p. 1049, doi. 10.1007/s10897-018-0220-1
- By:
- Publication type:
- Article
Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 5, p. 716, doi. 10.1513/AnnalsATS.202308-673OC
- By:
- Publication type:
- Article
Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 4, p. 595, doi. 10.1513/AnnalsATS.202306-576OC
- By:
- Publication type:
- Article
Amikacin Liposome Inhalation Suspension for Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
One-year safety and efficacy of tobramycin powder for inhalation in patients with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2016, v. 51, n. 4, p. 372, doi. 10.1002/ppul.23358
- By:
- Publication type:
- Article
A role for aerosolized antibiotics.
- Published in:
- Pediatric Pulmonology, 2008, v. 43, n. S9, p. S29, doi. 10.1002/ppul.20859
- By:
- Publication type:
- Article
Superior vena cava syndrome related to indwelling intravenous catheters in patients with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2006, v. 41, n. 7, p. 683, doi. 10.1002/ppul.20388
- By:
- Publication type:
- Article
Transition programs in cystic fibrosis centers: Perceptions of team members.
- Published in:
- Pediatric Pulmonology, 2004, v. 37, n. 1, p. 4, doi. 10.1002/ppul.10391
- By:
- Publication type:
- Article
Transition programs in cystic fibrosis centers: Perceptions of patients.
- Published in:
- Pediatric Pulmonology, 2002, v. 33, n. 5, p. 327, doi. 10.1002/ppul.10083
- By:
- Publication type:
- Article
Transition programs in cystic fibrosis centers: Perceptions of pediatric and adult program directors.
- Published in:
- Pediatric Pulmonology, 2001, v. 31, n. 6, p. 443, doi. 10.1002/ppul.1073
- By:
- Publication type:
- Article
Improvements in anthropometric measures and gastrointestinal tolerance in patients with cystic fibrosis by using a digestive enzyme cartridge with overnight enteral nutrition.
- Published in:
- Nutrition in Clinical Practice, 2022, v. 37, n. 2, p. 344, doi. 10.1002/ncp.10831
- By:
- Publication type:
- Article
Best Practices in the Treatment and Management of Cystic Fibrosis: Recent Updates and Advances in CFTR Therapy.
- Published in:
- Journal of Managed Care Medicine, 2021, v. 24, n. 2, p. 61
- By:
- Publication type:
- Article
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of a Reduction in Susceptibility Testing for in a Cystic Fibrosis Program.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Complex (CONVERT). A Prospective, Open-Label, Randomized Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2017, v. 195, n. 6, p. 814, doi. 10.1164/rccm.201604-0700oc
- By:
- Publication type:
- Article
Aerosolized Antibiotics for Patients with Bronchiectasis.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Prioritizing studies of COVID-19 and lessons learned.
- Published in:
- Journal of Clinical & Translational Science, 2021, v. 5, n. 1, p. 1, doi. 10.1017/cts.2021.784
- By:
- Publication type:
- Article
Managing the risks and benefits of clinical research in response to a pandemic.
- Published in:
- Journal of Clinical & Translational Science, 2021, v. 5, n. 1, p. 1, doi. 10.1017/cts.2021.14
- By:
- Publication type:
- Article
4224 Development of a Patient Registry and Biospecimen Repository to Identify Biomarkers in Nontuberculous Mycobacteria Lung Disease.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
4433 SGRQ score is associated with treatment status for patients with non-tuberculous mycobacterial lung disease.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Optimising inhaled mannitol for cystic fibrosis in an adult population.
- Published in:
- Breathe, 2015, v. 11, n. 1, p. 39, doi. 10.1183/20734735.021414
- By:
- Publication type:
- Article
Not all phenotypes are created equal: covariates of success in e-phenotype specification.
- Published in:
- Journal of the American Medical Informatics Association, 2023, v. 30, n. 2, p. 213, doi. 10.1093/jamia/ocac157
- By:
- Publication type:
- Article
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 10, p. 1812, doi. 10.1093/cid/ciz364
- By:
- Publication type:
- Article
Lung clearance index. A potential quantitative tool to assess treatment response in bronchiectasis?
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Lung Clearance Index: A Potential Quantitative Tool to Assess Treatment Response in Bronchiectasis?
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2014, v. 189, n. 5, p. 510, doi. 10.1164/rccm.201401-0129ed
- By:
- Publication type:
- Article
Long Term Inhaled Dry Powder Mannitol in Cystic Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 185, n. 6, p. 645, doi. 10.1164/rccm.201109-1666OC
- By:
- Publication type:
- Article
Update in Cystic Fibrosis 2010.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2011, v. 183, n. 12, p. 1620, doi. 10.1164/rccm.201102-0275UP
- By:
- Publication type:
- Article
Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2011, v. 183, n. 11, p. 1510, doi. 10.1164/rccm.201008-1293OC
- By:
- Publication type:
- Article
Cystic Fibrosis Pulmonary Guidelines.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2010, v. 182, n. 3, p. 298, doi. 10.1164/rccm.201002-0157OC
- By:
- Publication type:
- Article
Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93857-7
- By:
- Publication type:
- Article
Is bronchiectasis really a disease?
- Published in:
- European Respiratory Review, 2020, p. 1, doi. 10.1183/16000617.0051-2019
- By:
- Publication type:
- Article
Response to Commentary: Regulatory Support Improves Subsequent IRB Approval Rates in Studies Initially Deemed Not Ready for Review—A CTSA Institution’s Experience.
- Published in:
- Journal of Empirical Research on Human Research Ethics, 2018, v. 13, n. 2, p. 148, doi. 10.1177/1556264617753316
- By:
- Publication type:
- Article
Regulatory Support Improves Subsequent IRB Approval Rates in Studies Initially Deemed Not Ready for Review: A CTSA Institution’s Experience.
- Published in:
- Journal of Empirical Research on Human Research Ethics, 2018, v. 13, n. 2, p. 139, doi. 10.1177/1556264617752725
- By:
- Publication type:
- Article
Airway-Clearance Therapy Guidelines and Implementation.
- Published in:
- Respiratory Care, 2009, v. 54, n. 6, p. 733, doi. 10.4187/002013209790983205
- By:
- Publication type:
- Article
Pulmonary Complications of Cystic Fibrosis.
- Published in:
- Respiratory Care, 2009, v. 54, n. 5, p. 618, doi. 10.4187/aarc0443
- By:
- Publication type:
- Article
Cystic Fibrosis Pulmonary Guidelines: Airway Clearance Therapies.
- Published in:
- Respiratory Care, 2009, v. 54, n. 4, p. 522
- By:
- Publication type:
- Article
Pulmonary exacerbations in insured patients with bronchiectasis over 2 years.
- Published in:
- ERJ Open Research, 2023, v. 9, n. 4, p. 1, doi. 10.1183/23120541.00021-2023
- By:
- Publication type:
- Article
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cystic Fibrosis: Translating Molecular Mechanisms into Effective Therapies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A New Era in Cystic Fibrosis Treatment: Small-Molecule Therapy.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 65
- By:
- Publication type:
- Article
Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome.
- Published in:
- Human Molecular Genetics, 2005, v. 14, n. 22, p. 3493, doi. 10.1093/hmg/ddi374
- By:
- Publication type:
- Article
The Cystic Fibrosis Survival Gap: Why Do Canadians Fare Better Than Americans?
- Published in:
- 2017
- By:
- Publication type:
- journal article
State of progress in treating cystic fibrosis respiratory disease.
- Published in:
- BMC Medicine, 2012, v. 10, n. 1, p. 88, doi. 10.1186/1741-7015-10-88
- By:
- Publication type:
- Article
Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion.
- Published in:
- 2022
- By:
- Publication type:
- journal article